Finance

Lists
Why is KYMR down ၄.၈၂%?
Dive Deeper
KYMR:NASDAQ
Kymera Therapeutics Inc
၁၀၆.၆၈ US$
-၄.၈၂%
(-၅.၄၀) 1D
၁၀၆.၆၈ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Open
၁၁၀.၈၃ US$
High
၁၁၂.၀၆ US$
Low
၁၀၆.၅၂ US$
Mkt. cap
၈၈၇.၀၅ ဋေ
Avg. vol.
၈.၀၇ သိန်း
Volume
၀.၀၀
52-wk high
၁၃၀.၀၅ US$
52-wk low
၅၅.၂၆ US$
EPS
-၃.၂၄ US$
Beta
၁.၉၈
Shares outstanding
၈.၃၂ ကုဋေ
No. of employees
၂၇၃
Open
၁၁၀.၈၃ US$
High
၁၁၂.၀၆ US$
Low
၁၀၆.၅၂ US$
Mkt. cap
၈၈၇.၀၅ ဋေ
Avg. vol.
၈.၀၇ သိန်း
Volume
၀.၀၀
52-wk high
၁၃၀.၀၅ US$
52-wk low
၅၅.၂၆ US$
EPS
-၃.၂၄ US$
Beta
၁.၉၈
Shares outstanding
၈.၃၂ ကုဋေ
No. of employees
၂၇၃
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၅ နာရီ
Raymond James set a USD 140.00 target for Kymera Therapeutics stock
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၁ ရက်
Understanding Momentum Shifts in (KYMR)
About Kymera Therapeutics Inc
CEO-
Employees၂၇၃
Founded၂၀၁၅
HeadquartersWatertown, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 16 analysts giving stock ratings to KYMR in the past 3 months
Strong buy
Buy
14
Hold
2
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for KYMR in the last 3 months.
Highest
Current ၁၀၆.၆၈ US$
၁၈၀.၀၀ US$ (+၆၈.၇၃%)
Average
၁၄၁.၅၀ US$ (+၃၂.၆၄%)
Lowest
၁၁၂.၀၀ US$ (+၄.၉၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Deal
Raymond James
Buy
Initiated
၁၄၀.၀၀ US$
+၃၁.၂%
10/08/2026
Unknown Analyst
Raymond James
Buy
Initiated
၁၄၀.၀၀ US$
+၃၁.၂%
10/08/2026
Geoff Meacham
Citi
Buy
Maintained
၁၅၀.၀၀ US$
+၄၀.၆%
10/05/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
၁၄၀.၀၀ US$
+၃၁.၂%
09/28/2026
Biren Amin
Piper Sandler
Buy
Maintained
၁၄၀.၀၀ US$
+၃၁.၂%
09/23/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
၁၅၂.၀၀ US$
+၄၂.၅%
09/22/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
၁၄၄.၀၀ US$
+၃၅%
09/14/2026
Andy Chen
Wolfe Research
Buy
Upgraded
၁၈၀.၀၀ US$
+၆၈.၇%
09/10/2026
Brian Abrahams
RBC Capital
Hold
Maintained
၁၁၂.၀၀ US$
+၅%
09/02/2026
Bradley Canino
Guggenheim
Buy
Reiterated
၁၇၀.၀၀ US$
+၅၉.၄%
08/30/2026
Derek Archila
Wells Fargo
Buy
Reiterated
၁၅၁.၀၀ US$
+၄၁.၅%
08/27/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
၁၃၅.၀၀ US$
+၂၆.၅%
08/06/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
၁၂၉.၀၀ US$
+၂၀.၉%
08/06/2026
David Dai
UBS
Buy
Maintained
၁၂၈.၀၀ US$
+၂၀%
08/05/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
၁၃၄.၀၀ US$
+၂၅.၆%
08/06/2026
Eliana Merle
Barclays
Buy
Maintained
၁၃၉.၀၀ US$
+၃၀.၃%
08/06/2026
David Hoang
Deutsche Bank
Hold
Initiated
၁၂၀.၀၀ US$
+၁၂.၅%
07/29/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
၁၄၀.၀၀ US$
+၃၁.၂%
07/16/2026
Daniel Giraldo
Bank of America Securities
Buy
Reiterated
၁၂၅.၀၀ US$
+၁၇.၂%
06/29/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
၁၃၆.၀၀ US$
+၂၇.၅%
06/29/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
၁၅၅.၀၀ US$
+၄၅.၃%
06/29/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
၁၅၅.၀၀ US$
+၄၅.၃%
06/26/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
၁၁၆.၀၀ US$
+၈.၇%
06/26/2026
Jeet Mukherjee
BTIG
Buy
Maintained
၁၃၄.၀၀ US$
+၂၅.၆%
06/25/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/05/2026
Kelly Shi
Jefferies
Buy
Initiated
၁၁၀.၀၀ US$
+၃.၁%
03/15/2026
Faisal Khurshid
Jefferies
Buy
Initiated
၁၁၀.၀၀ US$
+၃.၁%
03/15/2026
Sudan Loganathan
Stephens
Buy
Maintained
၁၀၀.၀၀ US$
-၆.၃%
03/02/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
၁၂၀.၀၀ US$
+၁၂.၅%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၂.၇၆ သန်း
၂.၈၇ သန်း
၃.၄၄ ကုဋေ
၆.၅၀ ကုဋေ
Cost of goods sold
၇.၄၁ ကုဋေ
၈.၃၈ ကုဋေ
၉.၈၂ ကုဋေ
၁၁.၉၅ ကုဋေ
Cost of revenue
၇.၄၁ ကုဋေ
၈.၃၈ ကုဋေ
၉.၈၂ ကုဋေ
၁၁.၉၅ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၇၃ ကုဋေ
၁.၆၉ ကုဋေ
၂.၀၄ ကုဋေ
၂.၁၁ ကုဋေ
Operating expense
၁.၇၃ ကုဋေ
၁.၆၉ ကုဋေ
၂.၀၄ ကုဋေ
၂.၁၁ ကုဋေ
Total operating expenses
၉.၁၄ ကုဋေ
၁၀.၀၈ ကုဋေ
၁၁.၈၅ ကုဋေ
၁၄.၀၆ ကုဋေ
Operating income
-၈.၈၇ ကုဋေ
-၉.၇၉ ကုဋေ
-၈.၄၂ ကုဋေ
-၇.၅၆ ကုဋေ
Other non operating income
-
-
၅.၀၀ ထောင်
-၂.၅၀ သောင်း
EBT including unusual items
-၈.၂၂ ကုဋေ
-၈.၇၀ ကုဋေ
-၆.၉၂ ကုဋေ
-၆.၁၂ ကုဋေ
EBT excluding unusual items
-၇.၈၃ ကုဋေ
-၈.၇၀ ကုဋေ
-၆.၉၂ ကုဋေ
-၆.၁၂ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၈.၂၂ ကုဋေ
-၈.၇၀ ကုဋေ
-၆.၉၂ ကုဋေ
-၆.၁၂ ကုဋေ
Net profit margin
-၂,၉၇၃.၀၅%
-၃,၀၃၀.၇၀%
-၂၀၁.၄၇%
-၉၄.၁၇%
Earnings per share
-၀.၉၄
-၀.၉၈
-၀.၇၁
-၀.၆၂
Interest and investment income
၁.၀၄ ကုဋေ
၁.၁၀ ကုဋေ
၁.၅၀ ကုဋေ
၁.၄၅ ကုဋေ
Interest expense
-၉.၈၀ သောင်း
-၉.၀၀ သောင်း
-၆.၆၀ သောင်း
-၅.၆၀ သောင်း
Net interest expenses
၁.၀၃ ကုဋေ
၁.၀၉ ကုဋေ
၁.၄၉ ကုဋေ
၁.၄၄ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
-၈.၅၈ ကုဋေ
-၉.၇၅ ကုဋေ
-၈.၂၁ ကုဋေ
-၇.၄၅ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ